A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1
Clinical trial NCT06462404 · COMPLETED
Trial details
- NCT number
- NCT06462404
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2025-03-17
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.